Detection of genomic variants in BRCA1 and BRCA2 across gastric cancer patients using next generation sequencing

被引:0
|
作者
Li, Fangfang
Abdel-Maksoud, Mostafa A. [1 ,2 ]
Ullah, Tahir [3 ]
Ul Haq, Moeen [4 ]
Khan, Abdurrehman [5 ]
Olatunji, Aliu Olalekan [6 ]
Abbasi, Bakar Bin Khatab [7 ]
Saleh, Ibrahim A. [8 ]
Rather, Mehak Nabi [9 ]
Al-Hawadi, Jehad S. [8 ]
Zomot, Naser [8 ]
Almutairi, Saeedah Musaed
Naz, Rida [10 ]
机构
[1] Jiaozhou Cent Hosp Qingdao, Dept Gastroenterol, Qingdao 266300, Shandong, Peoples R China
[2] King Saud Univ, Coll Sci, Bot & Microbiol Dept, POB 2455, Riyadh 11451, Saudi Arabia
[3] Bannu Med Coll, Bannu 28100, Pakistan
[4] Gomal Med Coll, Dera Ismail Khan 29050, Pakistan
[5] Gomal Med Coll, Med Dept, Dera Ismail Khan, Pakistan
[6] Inst Univ Toledo, Dept Med Microbiol & Immunol, Toledo, OH 43606 USA
[7] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA
[8] Zarqa Univ, Fac Sci, Zarqa 13110, Jordan
[9] North End Hosp, Taper Wari Pora, J&K, India
[10] Reg Blood Ctr, Dera Ismail Khan 29050, Pakistan
来源
关键词
Gastric cancer; NGS; BRCA genes; NEGATIVE BREAST-CANCER; GENE-EXPRESSION; DNA-REPAIR; MUTATIONS; THERAPY; PROGNOSIS; CARCINOMA; PATTERNS; SURVIVAL; PLATFORM;
D O I
10.62347/MRIE2131
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: To explore the landscape of BRCA1/2 mutations in gastric cancer patients. Methods: Next- generation sequencing (NGS), Sanger sequencing, reverse transcription quantitative polymerase chain reaction (RTqPCR), Immunohistochemistry, The Cancer Genome Atlas (TCGA), gnomAD, and DAVID. Results: With 95% of bases boasting a phred score surpassing 30 and a minimum coverage depth of 500X, our NGS approach ensures high- quality data acquisition. Analyzing BRCA1 and BRCA2 sequences revealed 11 and 4 mutations, respectively, with one pathogenic mutation identified in each gene. This emphasizes the prominence of BRCA1 mutations in gastric cancer. Sanger sequencing validation confirmed the presence of pathogenic mutations in select cases, consolidating our findings. Frequency analysis utilizing the gnomAD database elucidated the rarity of these mutations in the Asian population, underscoring their uniqueness. Exploring TCGA data further corroborated this rarity, emphasizing the distinctive nature of these mutations in gastric cancer. RT-qPCR analysis unveiled a significant reduction in BRCA1/2 expression in samples harboring pathogenic mutations, hinting at their potential role in down-regulating gene expression. Immunohistochemistry confirmed diminished protein expression in samples with pathogenic mutations, solidifying our observations. Kaplan-Meier survival analysis demonstrated significantly poorer survival outcomes for patients with pathogenic BRCA1/2 mutations compared to those without, emphasizing their potential role in prognosis. Additionally, KEGG pathway analysis highlighted the involvement of BRCA1/2 in critical cancer- associated pathways, emphasizingtheir role in tumorigenesis. Conclusion: Our comprehensive findings underscore the clinical significance of BRCA1/2 mutations in gastric cancer, advocating for further research to elucidate their mechanistic implications and therapeutic opportunities.
引用
收藏
页码:7898 / 7910
页数:13
相关论文
共 50 条
  • [31] Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants
    Li, Shuai
    Silvestri, Valentina
    Leslie, Goska
    Rebbeck, Timothy R.
    Neuhausen, Susan L.
    Hopper, John L.
    Nielsen, Henriette Roed
    Lee, Andrew
    Yang, Xin
    McGuffog, Lesley
    Parsons, Michael T.
    Andrulis, Irene L.
    Arnold, Norbert
    Belotti, Muriel
    Borg, Ake
    Buecher, Bruno
    Buys, Saundra S.
    Caputo, Sandrine M.
    Chung, Wendy K.
    Colas, Chrystelle
    Colonna, Sarah, V
    Cook, Jackie
    Daly, Mary B.
    de la Hoya, Miguel
    de Pauw, Antoine
    Delhomelle, Helene
    Eason, Jacqueline
    Engel, Christoph
    Evans, D. Gareth
    Faust, Ulrike
    Fehm, Tanja N.
    Fostira, Florentia
    Fountzilas, George
    Frone, Megan
    Garcia-Barberan, Vanesa
    Garre, Pilar
    Gauthier-Villars, Marion
    Gehrig, Andrea
    Glendon, Gord
    Goldgar, David E.
    Golmard, Lisa
    Greene, Mark H.
    Hahnen, Eric
    Hamann, Ute
    Hanson, Helen
    Hassan, Tiara
    Hentschel, Julia
    Horvath, Judit
    Izatt, Louise
    Janavicius, Ramunas
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (14) : 1529 - +
  • [32] Haplotype analysis of BRCA1/BRCA2 variants in Korean patients with breast cancer
    Kwon, Won Kyung
    Jang, Hyeok-Jae
    Jang, Ja-Hyun
    Lee, Jeong Eon
    Park, Yeon Hee
    Kim, Jong-Won
    GENETIC EPIDEMIOLOGY, 2020, 44 (05) : 489 - 490
  • [33] CLINICOPATHOLOGICAL CHARACTERISTICS AND BRCA1 /BRCA2 PATHOGENIC VARIANTS OF PATIENTS WITH BREAST CANCER
    Eras, Nazan
    Tuncel, Ferah
    Altintas, Zuhal
    Erden, Sema
    POLISH JOURNAL OF PATHOLOGY, 2024, 75 (01) : 1 - 7
  • [34] Genomic rearrangements in the BRCA1 and BRCA2 genes
    Mazoyer, S
    HUMAN MUTATION, 2005, 25 (05) : 415 - 422
  • [35] Characterization of common BRCA1 and BRCA2 variants
    Deffenbaugh, AM
    Frank, TS
    Hoffman, M
    Cannon-Albright, L
    Neuhausen, SL
    GENETIC TESTING, 2002, 6 (02): : 119 - 121
  • [36] Comparison of the Diagnostic Accuracy of Next Generation Sequencing and Microarray Resequencing Methods for Detection of BRCA1 and BRCA2 Gene Mutations
    Bahsi, Taha
    Ergun, Sezen Guntekin
    Ergun, Mehmet Ali
    Percin, E. Ferda
    GAZI MEDICAL JOURNAL, 2018, 29 (02): : 116 - 118
  • [37] The Use of Internal Controls in Next-Generation Sequencing to Improve BRCA1 and BRCA2 Gene Copy Loss Detection
    Lo, B.
    Morrison, T.
    Yeung, B.
    Austermiller, B.
    Chirip, V.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (11): : S168 - S168
  • [38] Gastric Cancer Risk and Pathogenesis in BRCA1 and BRCA2 Carriers
    Buckley, Kole H.
    Niccum, Blake A.
    Maxwell, Kara N.
    Katona, Bryson W.
    CANCERS, 2022, 14 (23)
  • [39] Analysis of pathogenic variants in BRCA1 and BRCA2 genes using next-generation sequencing in women with triple negative breast cancer from South India
    Rajagopal, Taruna
    Seshachalam, Arun
    Jothi, Arunachalam
    Rathnam, Krishna Kumar
    Talluri, Srikanth
    Venkatabalasubranian, Sivaramakrishnan
    Dunna, Nageswara Rao
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (04) : 3025 - 3032
  • [40] Analysis of pathogenic variants in BRCA1 and BRCA2 genes using next-generation sequencing in women with triple negative breast cancer from South India
    Taruna Rajagopal
    Arun Seshachalam
    Arunachalam Jothi
    Krishna Kumar Rathnam
    Srikanth Talluri
    Sivaramakrishnan Venkatabalasubranian
    Nageswara Rao Dunna
    Molecular Biology Reports, 2022, 49 : 3025 - 3032